A users' guide to understanding therapeutic substitutions

Edward J. Mills; David Gardner; Kristian Thorlund; Matthias Briel; Stirling Bryan; Brian Hutton; Gordon H. Guyatt

doi:10.1016/j.jclinepi.2013.09.008

A users' guide to understanding therapeutic substitutions

Edward J. Mills, David Gardner, Kristian Thorlund, Matthias Briel, Stirling Bryan, Brian Hutton, Gordon H. Guyatt

Pharmacology, Toxicology and Pharmaceutics

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	305-313
Number of pages	9
Journal	Journal of Clinical Epidemiology
Volume	67
Issue number	3
DOIs	https://doi.org/10.1016/j.jclinepi.2013.09.008
Publication status	Published - Mar 2014

ASJC Scopus Subject Areas

Epidemiology

Access to Document

10.1016/j.jclinepi.2013.09.008

Cite this

@article{c0dccd82cb34446f9dbcd7fabb086697,

title = "A users' guide to understanding therapeutic substitutions",

author = "Mills, {Edward J.} and David Gardner and Kristian Thorlund and Matthias Briel and Stirling Bryan and Brian Hutton and Guyatt, {Gordon H.}",

note = "Funding Information: E.J.M. and K.T. have consulted either Merck & Co Inc, Pfizer Ltd, Novartis, Takeda, or Glaxo Smithkline on MTC issues. E.J.M. and K.T. have received grant funding from the Canadian Institutes of Health Research (CIHR) Drug Safety & Effectiveness Network to develop methods and educational materials on MTCs . E.J.M. receives salary support from the CIHR through a Canada Research Chair . K.T. receives salary support from the CIHR Drug Safety & Effectiveness Network . D.G. has completed an investigator-initiated grant funded by Pfizer . There are no other relevant competing interests. E.J.M. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. ",

year = "2014",

month = mar,

doi = "10.1016/j.jclinepi.2013.09.008",

language = "English",

volume = "67",

pages = "305--313",

journal = "Journal of Clinical Epidemiology",

issn = "0895-4356",

publisher = "Elsevier USA",

number = "3",

}

TY - JOUR

T1 - A users' guide to understanding therapeutic substitutions

AU - Mills, Edward J.

AU - Gardner, David

AU - Thorlund, Kristian

AU - Briel, Matthias

AU - Bryan, Stirling

AU - Hutton, Brian

AU - Guyatt, Gordon H.

N1 - Funding Information: E.J.M. and K.T. have consulted either Merck & Co Inc, Pfizer Ltd, Novartis, Takeda, or Glaxo Smithkline on MTC issues. E.J.M. and K.T. have received grant funding from the Canadian Institutes of Health Research (CIHR) Drug Safety & Effectiveness Network to develop methods and educational materials on MTCs . E.J.M. receives salary support from the CIHR through a Canada Research Chair . K.T. receives salary support from the CIHR Drug Safety & Effectiveness Network . D.G. has completed an investigator-initiated grant funded by Pfizer . There are no other relevant competing interests. E.J.M. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PY - 2014/3

Y1 - 2014/3

UR - http://www.scopus.com/inward/record.url?scp=84894981036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894981036&partnerID=8YFLogxK

U2 - 10.1016/j.jclinepi.2013.09.008

DO - 10.1016/j.jclinepi.2013.09.008

M3 - Review article

C2 - 24291506

AN - SCOPUS:84894981036

SN - 0895-4356

VL - 67

SP - 305

EP - 313

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

IS - 3

ER -

A users' guide to understanding therapeutic substitutions

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this